Guide Infrared Donates Infrared Fever Screening System worth $144,000 to Japan

Food and Healthcare Press Releases Friday March 6, 2020 14:25
China--6 Mar--PRNewswire/InfoQuest
  • Guide Infrared joins Japan's fight against COVID-19 with a donation of Infrared Fever Screening Systems

Guide Infrared, a leading Chinese manufacturer of infrared thermal imaging systems based in Wuhan, China, has donated GUIDE IR Fever Warning Systems to Japan. The automatic infrared thermal imaging systems with AI algorithm provide efficient and accurate non-contact temperature screening and alert operators when a fever is detected -- valued at over RMB1 million (approx. US$144,000).

"Social commitment is deeply rooted in Guide Infrared's corporate DNA and fighting the Novel Coronavirus epidemic has become a global responsibility. As a result, Guide Infrared has decided to join the fight to prevent further spread of the disease by donating the latest thermal imaging systems," said Mr Huang Sheng, CEO of Guide Sensmart. As a subsidiary of Guide Infrared, Guide Sensmart is responsible for the commercial business of infrared thermal imaging industry

Acting quickly, Guide Infrared collected the epidemic prevention supplies and equipment and delivered them to Japan by the end of February, and they will soon be put into use at hospitals and epidemic prevention stations across the country.

Guide Infrared, a leader in China's infrared thermal imaging system market, has a proven track record of supporting epidemic prevention with temperature measurement solutions. From the 2003 SARS pandemic, the 2009 H1N1 Influenza pandemic and the 2014 Ebola epidemic, to the COVID-19 outbreak, the firm has stood with society in the prevention of disease.

The donated devices include the IR236 automated IR Fever Screening Systems equipped with infrared thermal imaging and the IR236, a proprietary infrared detector that can help reduce the risk of infection caused by prolonged, unprotected close contact with a patient by quickly identifying fever patients within 10 meters. Thanks to the combination of big data, artificial intelligence, face recognition, the IR236 is user-friendly and delivers accurate results. The solution can be applied in crowded places, such as airports, railway stations, hospitals, banks, large factories, schools, shopping malls and supermarkets as well as residential communities.

Photo -
Caption: The medical supplies donated by Guide Infrared
Photo -
Caption: The applications of GUIDE IR Fever Screening System

Latest Press Release

Ansell Urges Global Priority For Supply Of Personal Protective Equipment

Ansell Limited, a global leader in protective solutions, is working with governments and health organizations worldwide to ensure unrestricted personal protective equipment (PPE) manufacture and supply is given top priority during the COVID-19...

Yiling Pharmacy Lianhua Qingwen has been approved by the Thai FDA

On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the Food and Drug Administration of Thailand. Lianhua Qingwen Capsule is recognized as in...

EW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions

Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as...

Saxenda(R) Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

Novo Nordisk today announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda(R) (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted...

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson...

Related Topics